½÷¥ß¬ã¨s³¡§Ö°T
¬d¬Ý©õ¤é¬ã¨s³¡§Ö°T Âà±Hµ¹ªB¤Í §K¶O­q¾\ ·N¨£´£¨Ñ English Version
Phillip Home   6¤ë11¤é (¬P´Á¤G)

 

¨ó¦X·s¯à·½(182)
¸Ñºc¡G
¨ó¦X·s¯à·½(182)¥D­n±q¨Æ§ë¸ê¤Î¹BÀç­·¤O¤Î¤Ó¶§¯àµo¹q¹q¼t¡A¦P®É¥ç´£¨Ñ³]­p¡B§Þ³N¤Î¿Ô¸ßªA°È¡A©ÓÅó¹q¼t¶µ¥Ø¤§¹q¤O¤uµ{³]­p¤Î¬I¤u¡A´£¨Ñ¿Ä¸ê¯²¸îªA°È¤Î¯à·½ª«ÁpºôªA°È¡C¶°¹Î¦b¦h­Ó°ê®a±À¶i°ê»Ú¥«³õ¥¬§½¡A¨Ã®Ú¾Ú¦U¦a°Ï¥i¦A¥Í¯à·½²£·~µo®i·s¬Fµ¦¡A°w¹ï©Ê¨î©w¶}µoµ¦²¤©M¤è®×¡A¤£Â_´£°ª¶µ¥ØÀx³Æ¡CºI¦Ü2023¦~12¤ë31¤é¡A¶°¹Î«ù¦³¨Ãºôµo¹qªº­·¹q¤Î¥ú¥ñ¹q¼tÅv¯q¸Ë¾÷®e¶q4,050MW¡A¨ä¤¤­·¹qÅv¯q¸Ë¾÷®e¶q3,467MW¡]¦û¤ñ85.6%¡^¡F¥ú¥ñÅv¯q¸Ë¾÷®e¶q583MW¡]¦û¤ñ14.4%¡^¡C¶°¹Î§ë¸êªº¹q¼t¤¤¡AµL¸É¶K­·¹q¡B¥ú¥ñ¶µ¥ØÅv¯q¸Ë¾÷®e¶q¤w¹F2,624MW¡A¦û¶°¹ÎÅv¯q¸Ë¾÷®e¶qªº64.8%¡C©ó2023¦~¡A¶°¹ÎÅv¯q¸Ë¾÷®e¶q¡BÅv¯qµo¹q¶q¡B²b§Q¼í¡B¨CªÑ¬Õ§Q¡B¨CªÑ²b¸ê²£¡B²b¸ê²£¦¬¯q²v¡B¤¤°ê¹Ò¤º·sÀò¨ú§ë¸ê¶µ¥Ø®e¶q¥H¤Î¦b«Ø¶µ¥Ø³W¼Òµ¥§¡³Ð¾ú¥v·s°ª¡C´Á¤º¹ê²{Àç·~ÃB25.88»õ¤¸¤H¥Á¹ô¡A¦P¤ñ¼Wªø7.8%¡FªÑªFÀ³¦û²b§Q¼í¬°9.63»õ¤¸¡A¼Wªø10.5%¡F°ò¥»¨CªÑ¬Õ§Q¬°11.42¤À¤H¥Á¹ô¡A¼Wªø15.35%¡CºI¦Ü2023¦~12¤ë31¤é¡A¨CªÑ²b¸ê²£¬°1.02¤¸¤H¥Á¹ô¡A¼Wªø12.1%¡A²{»ù¥«±b²v¬ù0.6­¿¡C©ó2023¦~¡A¶°¹Î¦b¤¤°ê¹Ò¤º·sÀò¨ú§ë¸ê¶µ¥Ø¦X­p2,099MW¡A¨ä¤¤­·¹q1,713MW¡A¥ú¥ñ 386MW¡C¦P®É·sñ­·¹q¸ê·½5,320MW¡B¥ú¥ñ¸ê·½2,600MW¡AÂ×´Iªº¸ê·½Àx³Æ¦³¤O«O»Ù¤F¥¼¨Óªº¥i«ùÄòµo®i¡C(µ§ªÌ¨S¦³«ù¦³¤W­zªÑ²¼)
µ¦²¤¡G
¶R¤J»ù$0.66¡A¥Ø¼Ð»ù$0.72¡A¤î»k»ù$0.62
 

µØ©ú¸Ë³Æ(002270.SZ)
¸Ñºc¡G
¤½¥q¬O°ê¤ºÅÜÀ£¾¹¦³¸ü¤À±µ¶}Ãö¦æ·~ªºÀsÀY¡A¥Ø«e°ê¤º¥«¥e²v¶W¹L90%¡A¥þ²y¥«³õ¥÷ÃB爲35%¡A¥Ø«e¤w¸g§Î¦¨¤À±µ¶}Ãö¡B¼Æ±±³]³Æ©M·s¯à·½¹q¯¸©Ó¥]3¤j·~°ÈªO¶ô¡C¤À±µ¶}Ãö¥D­n¥Î¤_¸ó¬Ù¹qºô¹q¤Oªº»·¶ZÂ÷¶Ç¿é©M¨Ñ¹q°Ï°ìªº½ÕÀ£Ã­À£¡C2024Q1¤½¥q¹ê²{¦¬¤J4.51»õ¤¸¡A¦P¤ñ+9.40%¡F¹ê²{Âk¥À²b§Q¼í1.27»õ¤¸¡A¦P¤ñ+7.59%¡C®Ú¾Ú°ê®a¹q¤O¦æ·~¼Ð·Ç¡A¤À±µ¶}Ãö¹B¦æ3-5¦~«áÀ³·í¶i¦æ¦QªäÀˬd¡A¤½¥q±N«ùÄò¨ü¯q¤_°ê¤º¹qºô§ë¸ê©M·s¯à·½¸Ë¾÷«ùÄò¼Wªø¡C¤½¥q®ü¥~¥«³õ¥¬§½¦h¦~¡A産«~¤w»·¾P¦Ü130¦h­Ó°ê®a©M¦a°Ï¡A¥Ø«e¥¿¦b¥[³t¥¬§½ªF«n¨È¡B¬ü°ê¡B¼Ú¬w¥«³õ¡A¥X®ü·~°È¦³±æ«ùÄò¼Wªø¡C
µ¦²¤¡G
¶R¤J»ù¢D21.20¡A¥Ø¼Ð»ù¢D25.10¡A¤î»k»ù¢D19.00

ùÚ¦w°ê»Ú (1044.HK) - FY2023·~°È¤´¿ý±oí°·¼Wªø¡B°ªºÝ°ª¤ò§Q²£«~«ùÄò¼Wªø
ùÚ¦w°ê»Ú³Ð¥ß©ó1985¦~¡A¬O¥Ø«e°ê¤º³Ì¤jªº¥Í¬¡¥Î¯È©M°ü¥®½Ã¥Í¥Î«~»s³y°Ó¡AºX¤U¾Ö¦³¦wº¸¼Ö¡B¤ß¬Û¦L¡B¤C«×ªÅ¶¡¡B¦w¨à¼Ö¥|ªT¤¤°ê¹£¦W°Ó¼Ð¡A½Ã¥Í¤y¡B¯È§¿¿Ç¡B¥Í¬¡¥Î¯È¤T¤j¥D¾É²£«~¦b°ê¤º¥«¦û²v¦W¦C«e­T¡C......§ó¦h

2024¦~²Ä¤@©u¡G´¼¯à¤â¾÷¥«³õªº°ª¶¥¤ÆÁͶÕ

ÀHµÛ2024¦~²Ä¤@©uªºµ²§ô¡A¥þ²y´¼¯à¤â¾÷¥«³õ¦A¦¸ÃÒ©ú¤F¨ä«ùÄòªº¦¨ªø°Ê¯à©M§Þ³Nºt¶iªº§Ö³t¨B¥ï¡C®Ú¾ÚCounterpoint Researchªº¼Æ¾Ú¡A¥þ²y´¼¯à¤â¾÷¥X³f¶q¦~¼W6%¡A¦ÓÁ`¦¬¤J§ó¬O¦~¼W7%¡A¹F¨ì­º©u¾ú¥v·s°ª¡C³o¶µ¦¨ÁZªº¨ú±o¡A¥D­n±o¯q©ó·s¿³¥«³õªº±j«l»Ý¨D¥H¤Î°ªºÝ³]³......§ó¦h


  • ¬ü°ê¹q°Ê¨®¥ø·~¯S´µ©Ô(Tesla)¦æ¬FÁ`µô°¨´µ§J(Elon Musk)ªí¥Ü¡A¦pªGÄ«ªG®e³\OpenAIºX¤U¤H¤u´¼¯à(AI)²á¤Ñ¾÷±ñ¤HChatGPT¡B»PÄ«ªGªº¾Þ§@¨t²ÎiOS¾ã¦X¡A¨º»ò¡A°¨´µ§J±N·|¤U¥O¡AºX¤U¤½¥q¸T¤îÄ«ªGªº³]³Æ¥X²{¡A¦]¬°³o·|¤Þµo¤£¥i±µ¨üªº¦w¥þ°ÝÃD¡C
  • °ê®aª÷¿ÄºÊºÞÁ`§½©M¦í©Ð«°¶m«Ø³]³¡¤é«eÁp¦X¦Lµo¡mÃö©ó¶i¤@¨Bµo´§«°¥«©Ð¦a²£¿Ä¸ê¨ó½Õ¾÷»s§@¥Î º¡¨¬©Ð¦a²£¶µ¥Ø¦X²z¿Ä¸ê»Ý¨Dªº³qª¾¡n¡A¡m³qª¾¡n­n¨D«°¥«¨ó½Õ¾÷¨î­t³d§â¦n¡u¥Õ¦W³æ¡v¶µ¥Ø­ã¤JÃö¤f¡C¡u¥Õ¦W³æ¡v¬O¦X³W¶µ¥Ø¦W³æ¡A­n²Å¦X5­Ó±ø¥ó©M5¶µ¼Ð·Ç¡C«°¥«¨ó½Õ¾÷¨î­n­t³d°µ¦nÁҰϤº©Ð¦a²£¦b«Ø¶µ¥Ø°T®§úÀÁ`¡B¡u¥Õ¦W³æ¡v¶µ¥Ø¼f®Ö±À°e¡B°ÝÃD¶µ¥Ø¾ã§ï¡B¶µ¥ØºÞ²zºÊ·þ¡A¥H¤Î¬°¶µ¥Ø¿Ä¸êªA°È´£¨Ñ°ò¥»«O»Ùµ¥¤u§@¡C
  • °ê»Ú°]¸g
    • ¼Ú¬w¥¡¦æ¦æªø©Ô¥[¼w(Christine Lagarde)ªí¥Ü¡A¼Ú¥¡¦æ¨Ã¨S¦³³B©ó¤@±ø¹w³]ªº§Q²v¸ô®|¤W¡C©Ô¥[¼w©P¤@¦b±µ¨ü¼Ú¬w³ø³¹Áp¦X±Ä³X®Éªí¥Ü¡A¼Ú¥¡¦æ§Q²v¨Ã¨S¦³³B©ó¤@±øª½½u¤U­°ªº¸ô®|¡A¥i¯à¦b¥¼¨Ó¤@¬q®É¶¡¤ººû«ù§Q²v¬Fµ¦¤£ÅÜ¡C
    • ¤¤°ê°ê°È°|Á`²z§õ±j¥D«ù¥l¶}°ê°È°|±`°È·|ij¡AÅ¥¨úÃö©ó·í«e©Ð¦a²£¥«³õ§Î¶Õ©M¤U¤@¨B¤u§@¦Ò¼{ªºúÀ³ø¡C·|ij«ü¥X¡A©Ð¦a²£·~µo®iÃö«Y¤H¥Á¸s²³¤Á¨­§Q¯q¡AÃö«Y¸gÀÙ¹B¦æ©Mª÷¿Äí©w¤j§½¡C­n¥R¤À»{ÃѩЦa²£¥«³õ¨Ñ¨DÃö«Yªº·sÅܤơA¶¶À³¤H¥Á¸s²³¹ïÀu½è¦í©Ðªº·s´Á«Ý¡AþÓ¤O±À°Ê¤w¥X¥x¬Fµ¦±¹¬I¸¨¦a¨£®Ä¡AÄ~Äò¬ã¨sÀx³Æ·sªº¥h®w¦s¡Bí¥«³õ¬Fµ¦±¹¬I¡C
    • ¤¤°ê¤H¥Á»È¦æ¤½¥¬¡A5¤ë©³¤¤°ê¥~úÀÀx³Æ¬°32320»õ¬ü¤¸¡A«ö¤ë¼W¥[312»õ¬ü¤¸¡A¤É´T¬°0.98%¡A³æ¤ë¼W´T³Ð¦~¤º³Ì¤j¡C°ê®a¥~úÀºÞ²z§½ºÙ¡A¨üúÀ²v§éºâ©M¸ê²£»ù®æÅܤƵ¥¦]¯Àºî¦X§@¥Î¡A·í¤ë¥~úÀÀx³Æ³W¼Ò¤W¤É¡C
  • ¥D­nÉ]³õ
    • ¤º¦a5¤ë¥~¶T¼Æ¾Ú°Ñ®t¡AAªÑ­Ó§Oµo®i¡C¤WÃÒ«ü¼Æ³Ì¦h¤É16ÂI©Î0.53%¡A°ª¨£3065ÂI«áªfÀ£´é²{¡A¤j¥«Âà¶^¡A´¿¶^17ÂI©Î0.58%¡A§C¨£3031ÂI«á¦³¶R½L§l¯Ç¦^í¡A¥þ¤é¦¬¥«³ø3051ÂI¡A¤É2ÂI©Î0.08%¡A¦¨¥æ3189.11»õ¤¸¤H¥Á¹ô¡C²`¦¨«ü³Ì¦h¤É26ÂI©Î0.28%¡A°ª¨£9366ÂI«á¥X²{©ÓÀ£¨«§C¡A³Ì¦h¶^158ÂI©Î1.69%¡A§C¨£9181ÂI¡A¥þ¤é¦¬¥«³ø9255ÂI¡A¶^84ÂI©Î0.9%¡A¦¨¥æ3979.01»õ¤¸¡C¥«³õ¥æ§ë°¾²H¡A¨â¥«¦¨¥æ¦X­pÁY´î¹O¤@¦¨¦Ü7168»õ¤¸¡C
    • ¨È¤Ó°ÏªÑ¥«­Ó§Oµo®i¡A¥«³õ»EµJ¥»©P¤½¥¬ªº¬ü°ê³qµÈ¼Æ¾Ú¤ÎÁpÀx§½Ä³®§µ²ªG¡A®Æ±N¨ã¦³«ü¼Ð§@¥Î¡C¤é¥»ªÑ¥«¤W¤É¡A¤é¸g¥­§¡«ü¼Æ¦¬³ø39038ÂI¡A¤É354ÂI©Î0.92%¡C
    • ¬ü°êÁpÀx§½©P¤G¶}©l¤@³s¨â¤éij®§¡A¥[¤W¼Ú¬w¬Fªv­·ÀIÆJ¼W¡A¥O§ë¸êªÌÁÍ©ó¼f·V¡A¬üªÑ©P¤@¤ÏÂЦ^í¡A¹D«ü§C¶}14ÂI«á¡A¶^´T´¿ÂX¤j¦Ü133ÂI¡A³Ì§C³ø38665ÂI¡F¼Ð«ü¤@«×¶^0.29%¡F¥H¬ì§ÞªÑ¬°¥Dªº¯Ç«ü³Ì¦h®À0.44%¡C¬ü¥«¦¬¥«¡A¹D«ü­Ë¤É69ÂI©Î0.18%¡A³ø38868ÂI¡F¼Ð«üº¦0.26%¡A³ø5360ÂI¡F¯Ç«ü¤W´­0.35%¡A³ø17192ÂI¡C
  • Àô²yºîµû
    • ¦bªk°êÁ`²Î°¨§JÀs«Å¥¬´£«eÁ|¦æ¤j¿ï«á¡A¼Ú¤¸§I¬ü¤¸«æ¶^¡A¤@«×¶^¦Ü1.0733¬ü¤¸ªº¹O1­Ó¤ë§C¦ì¡C¦b¯Ã¬ù§À¥«¡A¼Ú¤¸¶^¹O0.3%¡A¸û¦­®É³ø1.0762¬ü¤¸¡C¬ü¤¸«ü¼Æ¤@«×¤É¦Ü105.39ªºªñ1­Ó¤ë°ª¦ì¡A¦b§À¥«¤Éªñ0.1%¡A³ø105.13¡C

    ¥æ©ö­ûÀR«Ý¬ü°ê©P¤T¤½¥¬³qµÈ¼Æ¾Ú»PÁpÀx§½¤½¥¬Ä³®§µ²ªGªº®ø®§¡Aª÷¥«Æ[±æ®ðª^¿@¯P¡Aª÷»ù©P¤@±q§C¦ì¤Ï¼u¡C¯Ã¬ù´Áª÷¦¬¥«¤É0.1%¡A¨C¯s´µ³ø2327¬ü¤¸¡C...... §ó¦h

    ¦ÊÀÙ¯«¦{ (6160.HK)
    ¬ã¨s³ø§i: ¦ÊÀÙ¯«¦{(6160.HK) : ¥Ø¼Ð»ù122.00´ä¤¸¡C¦ÊÀÙ¯«¦{¦¨¥ß©ó 2010 ¦~¡A¬O¥»¤g³Ð·sÃÄ¥X®üÀsÀY¡A»EµJ¤_¸~½Fªº³Ð·s«¬¤À¤l¹v¦V¤Î¸~½F§K¬ÌªvÀøÃĪ«ªº¬ãµo¤Î°Ó·~¤Æ¡A¬O­º®a¹ê²{¬üªÑ+HªÑ+AªÑ¤T¦a¤W¥«ªº³Ð·sÃÄ¥ø·~¡C¤½¥q¹ê¤O¨ô¶V¡A¨ã³Æ¦­´ÁÃĪ«µo²{¡BÁ{§É¬ã¨s¡B³W¼Ò¤Æªº°ª½è¶qÃĪ«¥Í²£¤Î°Ó·~¤Æµ¥¥þ¤è¦ì¤@Åé¤Æ¯à¤O¡C¤½¥qªº¥|­Ó¥D­nªÑªF¥]¬A¦w¶i¡BBaker Brothers Life Sciences, L.P.¤Î¨ä¤@­P¦æ°Ê¤H¡BHHLR Fund, L.P.¤Î¨ä¤@­P¦æ°Ê¤H¡BCapital Research and Management Company ¤Î¨ä¤@­P¦æ°Ê¤H¤À§O«ùªÑ 18.25%¡B11.30%¡B10.89%¡B7.92%¡A¨ä¤¤³Ì¤jªÑªF¦w¶i¡A¬O¥þ²y±Æ¦W«e20 ¦ìªº¥Íª«ÂåÃĤ½¥q¡C¦ÊÀÙ¯«¦{ªººÞ½u«p«×¤Î¦h¼Ë¤Æµ{«×¦ì©~¥þ²yÄvª§«e¦C¡C¥Ø«e³B©óÁ{§É¤Î°Ó·~¤Æ¶¥¬qªºÃĪ«¬ù 50 ­Ó¡A¤w¤W¥«ÃĪ« 16 ­Ó¡]¥]¬A¦Û¬ã²£«~ 3 ­Ó¡^¡A³B©óÁ{§É¢»´Á¶¥¬qªºÃĪ« 3­Ó¡A³B©óÁ{§É¢º´Á¶¥¬qªºÃĪ« 13 ­Ó¡A³B©óÁ{§É¢¹´Á¶¥¬qªºÃĪ« 18 ­Ó¡C¥t¥~¾Ö¦³ 60 §E¶µÁ{§É«e·sÃĶµ¥Ø¡A³o¨ÇÃĪ«Ãþ«¬¯A¤Î¤p¤À¤lÃÄ¡B³æ§Ü¡BÂù§Ü¡BADC µ¥¦hºØÃþ«¬¡A¦h´ÚÃĪ«¨ã³Æ®t²§¤Æ¤D¦Ü¡§first-in-class¡¨¼ç¤O¡CÂ×´I¡B¦h¤¸¤Æªº¬ãµoºÞ½u¼sªxÂл\¤F¥þ²y 80%ªºÀù¯gÃþ«¬¡]«öµo¯f²v­pºâ¡^¡C¦b¦Û¬ã¤è­±¡A¦ÊÀÙ¾Ö¦³¨ô¶Vªº¤º³¡¶}µo¯à¤O¡A¾Ö¦³¶W 900 ¤HªºÁ{§É«e¬ã¨s¹Î¶¤¡A¦Û¥D¬ãµo²£«~¤¤¥Ø«e¦@¦³ 11 ´Ú²£«~¶i¤J¨ì°Ó·~¤Æ¶¥¬q¤ÎÁ{§É¹êÅ綥¬q¡A¨ä¤¤¦³ 3 ´Ú¤w¸gÀò§å¤W¥«¡A¤À§O¬°¿A¥¬´À¥§½¦Ån¡B´À¹p§Q¯]³æ§Üª`®g²G¡B©¬¦Ì©¬§Q½¦Ån¡A¥t¥~ 8 ´Ú²£«~³B©óÁ{§É¹êÅ綥¬q¡A¥B¬°®t²§¤Æ³]­pªº³Ð·sÃĪ«¡C¦b¦X§@¤è­±¡A¦ÊÀÙ¯«¦{ License in/out±j¤j¡ABD ¯à¤O³B©ó¥þ²y«e¦C¡A2017 ¦~»P·s°ò¤½¥q¡]²{ÁõÄݤ_¦Ê®É¬ü¬I¶QÄ_¡^¹F¦¨¦X§@¡A2019 ¦~©³»P¦w¶i­q¥ß¦X§@¨óij¡A2021 ¦~ 1 ¤ë»P 12 ¤ë¤À§O»P¿ÕµØ¹F¦¨¦X§@¡A¥ý«á¤Þ¶i13 ´Ú°Ó·~¤Æ²£«~ªº¤¤°êÅv¯q¡A¥]¬A¦w¶iªº¦w¥[ºû¡B­¿§Q§´¡B³Í¬¥´µ¡ABMS ªº·ç½Æ¬ü¡Bºû¹F²ï¡AEUSAPharmaªºÂÄ·ÅÏÈ¡B³Í¿A¦Ê¡A¦Ê¶ø®õªº´¶¨©§Æ¡A¥H¤Î¿ÕµØªº®õµá¼Ö¡BÁÚ¦NÚ¬¡Bºû¥þ¯S¡B­¸¥§§´¡BÃÙ¥i¹Fµ¥³Ð·s²£«~¡C¤½¥q¦bÁ{§É¶}µo¡BÁ{§Éµ¦²¤¡BÁ{§É°õ¦æµ¥¤è­±´I¦³¸gÅç¡A¥Ø«e¦b¥þ²y¾Ö¦³3,500+¥B¤´µM¤£Â_¼Wªøªº°Ó·~¤Æ¹Î¶¤¡A¨ä¤¤¤¤°ê¹Î¶¤3,000+¦W¡AÂл\¶W¹L 1,000 ®aÂå°|¡C¤½¥qªº¬ãµo§G§½¤wÂл\ ADC¡BÂù§Ü/¦h§Ü¡BCDAC¡]PROTAC¡^¡BCAR-NK¡BmRNA µ¥¦b¤ºªº¦hºØ¤j/¤p¤À¤lÃĪ«¥H¤Î·sªºÃĪ«§Î¦¡¡A¹w­p±N¦³±æ±a¨Ó«ùÄòªº³Ð·s²£«~¿é¥X¡C°]°È¼Æ¾ÚÅã¥Ü¡A¤½¥qªñ¤­¦~Àç·~¦¬¤J¡B²£«~Á`¦¬¤J¤Î®Ö¤ß²£«~¦¬¤J«ùÄò«O«ù°ª³t¼Wªø¡A¬ãµo¶O¥Î¤Î¾P°â/ºÞ²z¶O¥Î¼W³t«ùÄò©ñ½w¡A¨ä¸gÀçÁ«·l¦b 2022 ¦~ªï¨Ó­º¦¸´îÁ«¡A¸gÀç©Ê¬Õ§Q©äÂI¦³±æ¨ì¨Ó¡C2023¦~¡A¤½¥q¹ê²{Àç·~¦¬¤J174.2 »õ¤¸¡A¤ñ¤W¦~¦P´Á¼W¥[82.13%¡F¹ê²{²bÁ«·l67.2 »õ¤¸¡A¤ñ¤W¦~¦P´Á´î¤Ö69.3 »õ¤¸¡F³ø§i´Á¤º¡A¸gÀ笡°Ê²£¥Íªº²{ª÷¬y¶q²bÃB¬°-77.9»õ¤¸¡F¥þ¦~¬ãµo§ë¤J¬°128.1 »õ¤¸¡A»P¤W¦~¦P´Á¬Û¤ñ¼Wªø14.90%¡C2024¦~¤@©u«×¡A¤½¥q¹ê²{Àç·~¦¬¤J53.59»õ¤¸¡A¦P¤ñ¼Wªø74.8%¡F¹ê²{ÂkÄݤ_¤W¥«¤½¥qªÑªFªº²b§Q¼í-19.08»õ¤¸¡A¤W¦~¦P´Á¬°-26.13»õ¤¸¡AÁ«·l¦P¤ñÁY¤p¡C¦ÊÀÙ²£«~²Õ¦X¤´³B©ó°ª³t¼WªøºA¶Õ¡A¦b²£«~¦¬¤J«O«ù°ª¼W³tªº±¡ªp¤U¡A¤½¥qªº¥«­È¤ô¥­±N«ùÄò´£¤É¡C


    ¥«ªp¤ÀªR¡G¨È¤Ó°ÏªÑ¥«­Ó§Oµo®i¡A¥«³õ»EµJ¥»©P¤½¥¬ªº¬ü°ê³qµÈ¼Æ¾Ú¤ÎÁpÀx§½Ä³®§µ²ªG¡A®Æ±N¨ã¦³«ü¼Ð§@¥Î¡C¤é¥»ªÑ¥«¤W¤É¡A¤é¸g¥­§¡«ü¼Æ¦¬³ø39038ÂI¡A¤É354ÂI©Î0.92%¡C......§ó¦h

    ¥»¦a«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    Àô²y«ü¼Æ
           ÂI¼Æ    ¤É¶^   ¤É¶^%

    A-H·¸»ù(§éÅý) ªí
    ¥N¸¹ ¤½¥q¦WºÙ H ªÑ
    ¦¬¥«»ù
    A ªÑ
    ¦¬¥«»ù
    A - H
    ·¸»ù

    ¨ä¥L
       ÂI¼Æ     ¤É¶^   ¤É¶^%
      
      


    ®ü¥~¬ã¨s³ø§i


    §ë¸êªA°È¤¤¤ß


    ¬d¸ß¼ö½u¡G2277 6666 ©Î investornotes@phillip.com.hk
    ¦pªG­¶­±Åã¥Ü¤£¥¿±`½ÐÂIÀ» ¦¹³B¬d¬Ý³sµ²©ó¸Uºûºô¤Wªºª©¥»¡C
     

    ¥»¤å©Ò¥]§tªº¸ê®Æ§¡¬°½÷¥ßµý¨é(­»´ä)¦³­­¤½¥q©Î¨äªþÄݤ½¥q (¡u¶°¹Î¡v) ±q¬Û«H¬°·Ç½Tªº¨Ó·½·j¶°¡A¦ý¹ï¥ô¦ó¦]«H¿à©Î°Ñ¦Ò¦³Ãö¤º®e©Ò¾É­Pªº·l¥¢¡A·§¤£­t³d¡C¥»¶°¹Î (©Î¨ä¹µ­û) ¥i¯à«ù¦³¥»¤å©Ò­z¦³Ãöªº§ë¸ê²£«~¡C¦UÃþ²£«~ªº­·ÀI¡A½Ð°Ñ¾\¥»¤½¥qºô­¶ http://www.phillip.com.hk¡m­·ÀI©ÜÅSÁn©ú¡n¡C

    ¦p±z¤£·Q¦A¦¬¨ú¹q¤l±À¼s¶l¥ó¡A½Ð«ö¦¹³B¡C

    ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

    Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.